Skip to main content
. 2014 Feb;82(2):509–521. doi: 10.1128/IAI.01106-13

TABLE 2.

Oligonucleotides used in these studies

Primer Sequence (5′→3′)a Description
jf031912.1 TCCGAGCTCGAGATCCTTGTCACTTGCGTTATTAATGAATAAG (XhoI site underlined) yghJ forward cloning primer
jf031912.2 CCCAAGCTTCGAATTCTCGGCAGACATCTTATGCTC (HindIII site underlined) yghJ reverse cloning primer
jf082312.1 GCTGATCTGGCATGATGTCGGTCATAACGCC (GAA→GAT mutation underlined) Site-directed mutagenesis (E1309D) forward
jf082312.2 GGCGTTATGACCGACATCATGCCAGATCAGC Site-directed mutagenesis (E1309D) reverse
jf082312.3 GGCTGATCTGGCATGCAGTCGGTCATAACGC (GAA→GCA mutation underlined) Site-directed mutagenesis (E1309A) forward
jf082312.4 GCGTTATGACCGACTGCATGCCAGATCAGCC Site-directed mutagenesis (E1309A) reverse
jf112612.1 ACGACTGGCTGATCTGGGCTGAAGTCGGTCATAACG (CAT→GCT mutation underlined) Site-directed mutagenesis (H1308A) forward
jf112612.2 CGTTATGACCGACTTCAGCCCAGATCAGCCAGTCGT Site-directed mutagenesis (H1308A) reverse
jf112612.3 CTGGCATGAAGTCGGTGCTAACGCCGCAGAAACG (CAT→GCT mutation underlined) Site-directed mutagenesis (H1312A) forward
jf112612.4 CGTTTCTGCGGCGTTAGCACCGACTTCATGCCAG Site-directed mutagenesis (H1312A) reverse
jf101712.1 GACTGGCTGATCTGG(−66)AACGTGCTGGCGCTG Mutagenesis primer to construct 22-amino-acid internal deletion of YghJ residues H1308 to N1329
jf101712.2 CAGCGCCAGCACGTT(−66)CCAGATCAGCCAGTC Reverse complement of jf101712.1
jf101812.3 CCGAAGAAGAACCTGAATGC Forward sequencing primer yghJ from nt 3616 to 3635
jf101812.4 TTACCGTTGGATTCAGCACA Reverse sequencing primer yghJ from nt 4319 to 4300
a

(−66) indicates the position of the 66-nucleotide in-frame deletion in yghJ extending from nucleotide (nt) 3904 to 3969.